Summary

Persistence Market Research has recently released a comprehensive report on the global Bioresorbable Vascular Scaffold Market, offering a detailed evaluation of market dynamics such as growth drivers, restraints, opportunities, technological advancements, and competitive developments. The report is designed to provide stakeholders, investors, and industry participants with actionable insights into the evolving market landscape and future growth potential.

Key Insights:

• Bioresorbable Vascular Scaffold Market Size (2025E): US$ 314.4 Million
• Projected Market Value (2032F): US$ 592.8 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 8.3%

Bioresorbable Vascular Scaffold Market – Report Scope:

The global bioresorbable vascular scaffold market comprises advanced medical devices used in the treatment of coronary artery disease by providing temporary vascular support and gradually dissolving within the body over time. Unlike traditional metallic stents, bioresorbable vascular scaffolds are designed to restore natural vessel function while reducing long-term complications such as late thrombosis and chronic inflammation. The increasing prevalence of cardiovascular disorders, growing demand for minimally invasive procedures, and continuous innovation in biomaterials are key factors supporting market expansion. Additionally, rising awareness among healthcare professionals regarding the clinical benefits of bioresorbable technologies is contributing to wider adoption across developed and emerging healthcare systems.

Market Growth Drivers:

The growth of the global bioresorbable vascular scaffold market is primarily driven by the rising incidence of cardiovascular diseases worldwide, which continues to create demand for advanced interventional cardiology solutions. Increasing preference for minimally invasive procedures, coupled with favorable clinical outcomes associated with bioresorbable scaffolds, is significantly supporting market growth. Technological advancements in polymer science and scaffold design have improved device safety, efficacy, and absorption profiles, further accelerating adoption. Moreover, growing healthcare expenditure, expanding access to advanced cardiac care, and increasing investments in research and development by medical device manufacturers are reinforcing the market’s upward trajectory.

Market Restraints:

Despite strong growth prospects, the bioresorbable vascular scaffold market faces several notable challenges. High development and manufacturing costs associated with advanced biomaterials and complex production processes can limit widespread adoption, particularly in cost-sensitive healthcare markets. Clinical concerns related to scaffold thrombosis, mechanical strength, and long-term performance have also slowed market penetration in certain regions. In addition, stringent regulatory requirements and lengthy approval timelines for novel cardiovascular devices may delay product launches and restrict market growth.

Market Opportunities:

The market presents substantial growth opportunities driven by ongoing innovation in scaffold materials, drug-eluting technologies, and next-generation bioresorbable designs. Emerging economies offer untapped potential due to improving healthcare infrastructure, rising awareness of cardiovascular treatment options, and increasing patient populations. Strategic collaborations between medical device companies, research institutions, and healthcare providers are expected to accelerate product development and commercialization. Furthermore, advancements in personalized medicine and image-guided interventional procedures may create new avenues for bioresorbable vascular scaffold adoption in the coming years.

Key Questions Answered in the Report:

• What are the major factors driving the growth of the global bioresorbable vascular scaffold market?
• Which market segments and regions are expected to witness the highest growth during the forecast period?
• How are technological advancements influencing the development of bioresorbable vascular scaffolds?
• Who are the key players in the market, and what strategies are they adopting to strengthen their market position?
• What are the future trends and growth opportunities in the global bioresorbable vascular scaffold market?

Competitive Intelligence and Business Strategy:

Leading companies in the global bioresorbable vascular scaffold market are strategically focusing on innovation, clinical evidence generation, and strategic partnerships to strengthen their market position. Major players such as Abbott, Biotronik, Boston Scientific Corporation, and Meril Life Sciences Pvt. Ltd. are investing in research and development to enhance scaffold design, biocompatibility, and degradation profiles to address clinical concerns and improve patient outcomes. These investments are aimed at developing next-generation polymer and metal bioresorbable scaffolds with improved radial strength and safety.

Competitive Analysis:

• Meril Life Sciences Pvt. Ltd.
• Zeus Company LLC
• Biotronik
• Abbott
• MicroPort Scientific Corporation
• Kyoto Medical
• Elixir Medical (MedImpact Healthcare Systems, Inc.)
• Cigna
• B. Braun Melsungen AG
• Boston Scientific Corporation
• REVA Medical

Market Segmentation

By Product

• Metal Bioresorbable Vascular Scaffold
• Polymer Bioresorbable Vascular Scaffold

By Application

• Peripheral Artery
• Coronary Artery

By End-user

• Hospitals
• Ambulatory Care Centers
• Cardiac Centers
• Others

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Bioresorbable Vascular Scaffold Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-economic Factors
2.3.1. The development of biodegradable polymers and next-gen scaffold designs
2.3.2. Engineering of novel polymers with improved biocompatibility and controlled degradation rates
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Tool Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. PESTLE Analysis
3.5. Porter’s Five Force Analysis
4. Price Analysis, 2024A
4.1. Key Highlights
4.2. Key Factors Impacting Deployment Costs
4.3. Pricing Analysis, By Enterprise Type
5. Global Bioresorbable Vascular Scaffold Market Outlook
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
5.3. Global Bioresorbable Vascular Scaffold Market Outlook: Product
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
5.3.3.1. Metal Bioresorbable Vascular Scaffold
5.3.3.2. Polymer Bioresorbable Vascular Scaffold
5.3.4. Market Attractiveness Analysis: Product
5.4. Global Bioresorbable Vascular Scaffold Market Outlook: Application
5.4.1. Introduction / Key Findings
5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
5.4.3.1. Peripheral Artery
5.4.3.2. Coronary Artery
5.4.4. Market Attractiveness Analysis: Application
5.5. Global Bioresorbable Vascular Scaffold Market Outlook: End-user
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2024
5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
5.5.3.1. Hospitals
5.5.3.2. Ambulatory Surgical Centers
5.5.3.3. Cardiac Catheterization Labs
5.5.3.4. Others
5.5.4. Market Attractiveness Analysis: End-user
6. Global Bioresorbable Vascular Scaffold Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
6.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Bioresorbable Vascular Scaffold Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Product
7.2.3. By Application
7.2.4. By End-user
7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
7.4.1.
7.4.1.1. Metal Bioresorbable Vascular Scaffold
7.4.1.2. Polymer Bioresorbable Vascular Scaffold
7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
7.5.1. Peripheral Artery
7.5.2. Coronary Artery
7.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
7.6.1. Hospitals
7.6.2. Ambulatory Surgical Centers
7.6.3. Cardiac Catheterization Labs
7.6.4. Others
7.7. Market Attractiveness Analysis
8. Europe Bioresorbable Vascular Scaffold Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Product
8.2.3. By Application
8.2.4. By End-user
8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Turkey
8.3.8. Rest of Europe
8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
8.4.1.
8.4.1.1. Metal Bioresorbable Vascular Scaffold
8.4.1.2. Polymer Bioresorbable Vascular Scaffold
8.5. Market Size (US$ Mn) Analysis and Forecast, Application, 2025-2032
8.5.1. Peripheral Artery
8.5.2. Coronary Artery
8.6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025-2032
8.6.1. Hospitals
8.6.2. Ambulatory Surgical Centers
8.6.3. Cardiac Catheterization Labs
8.6.4. Others
8.7. Market Attractiveness Analysis
9. East Asia Bioresorbable Vascular Scaffold Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Product
9.2.3. By Application
9.2.4. By End-user
9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
9.4.1.
9.4.1.1. Metal Bioresorbable Vascular Scaffold
9.4.1.2. Polymer Bioresorbable Vascular Scaffold
9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
9.5.1. Peripheral Artery
9.5.2. Coronary Artery
9.6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025-2032
9.6.1. Hospitals
9.6.2. Ambulatory Surgical Centers
9.6.3. Cardiac Catheterization Labs
9.6.4. Others
9.7. Market Attractiveness Analysis
10. South Asia & Oceania Bioresorbable Vascular Scaffold Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Product
10.2.3. By Application
10.2.4. By End-user
10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
10.4.1.
10.4.1.1. Metal Bioresorbable Vascular Scaffold
10.4.1.2. Polymer Bioresorbable Vascular Scaffold
10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
10.5.1. Peripheral Artery
10.5.2. Coronary Artery
10.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
10.6.1. Hospitals
10.6.2. Ambulatory Surgical Centers
10.6.3. Cardiac Catheterization Labs
10.6.4. Others
10.7. Market Attractiveness Analysis
11. Latin America Bioresorbable Vascular Scaffold Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Product
11.2.3. By Application
11.2.4. By End-user
11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
11.4.1.
11.4.1.1. Metal Bioresorbable Vascular Scaffold
11.4.1.2. Polymer Bioresorbable Vascular Scaffold
11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
11.5.1. Peripheral Artery
11.5.2. Coronary Artery
11.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
11.6.1. Hospitals
11.6.2. Ambulatory Surgical Centers
11.6.3. Cardiac Catheterization Labs
11.6.4. Others
11.7. Market Attractiveness Analysis
12. Middle East & Africa Bioresorbable Vascular Scaffold Market Outlook
12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
12.2.1. By Country
12.2.2. By Product
12.2.3. By Application
12.2.4. By End-user
12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
12.4.1.
12.4.1.1. Metal Bioresorbable Vascular Scaffold
12.4.1.2. Polymer Bioresorbable Vascular Scaffold
12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
12.5.1. Peripheral Artery
12.5.2. Coronary Artery
12.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
12.6.1. Hospitals
12.6.2. Ambulatory Surgical Centers
12.6.3. Cardiac Catheterization Labs
12.6.4. Others
12.7. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Meril Life Sciences Pvt. Ltd.
13.3.1.1. Overview
13.3.1.2. Segments and Deployments
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Zeus Company LLC
13.3.3. Biotronik
13.3.4. Abbott
13.3.5. MicroPort Scientific Corporation
13.3.6. Kyoto Medical
13.3.7. Elixir Medical
13.3.8. Cigna
13.3.9. B. Braun Melsungen AG
13.3.10. Boston Scientific Corporation
13.3.11. REVA Medical
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations